Degradation of Fatty Acids
Degradation of Fatty Acids
Why Fat, Not Carbohydrates?
Fats are more reduced, yielding 9 kcal per gram compared to 4 kcal per gram for carbohydrates.
Fats are hydrophobic and can be stored without water, whereas carbohydrates are hydrophilic and bind water (1 gram carbohydrate binds 2 grams of H2O).
Triacylglycerols (TAGs) are the major energy reserve in the body, offering more efficient energy storage.
Fatty Acids as Fuels
Fatty acids are a major fuel for tissues; glucose is the major circulating fuel.
Fuel usage over 12 hours:
Fatty Acids (FA): 60 grams (540 kcal)
Glucose: 70 grams (280 kcal)
Release of Fatty Acids from TAG
Hormonal regulation:
Acetyl CoA carboxylase, crucial for fatty acid synthesis, is inhibited by the same signaling pathway as glucagon or epinephrine.
Perilipin coats fat droplets, blocking HSL (hormone-sensitive lipase). Phosphorylation by PKA releases perilipin.
Glycerol Metabolism in Liver and Adipose Tissues
Liver
Glycerol kinase phosphorylates glycerol to glycerol 3-phosphate.
Glycerol 3-phosphate can then be converted to dihydroxyacetone phosphate via glycerol 3-phosphate dehydrogenase, linking glycerol metabolism to glycolysis.
Adipose Tissue
Adipose tissue lacks glycerol kinase.
Glycerol 3-phosphate is produced from dihydroxyacetone phosphate, an intermediate in glycolysis, using glycerol 3-phosphate dehydrogenase.
Insulin promotes the uptake of glucose via GLUT-4, increasing the availability of dihydroxyacetone phosphate.
β-oxidation of Fatty Acids
Fatty acids are transported in the blood bound to albumin.
They are degraded by oxidation at the β-carbon, followed by cleavage of two-carbon units.
β-Oxidation Overview
The process involves the following:
Activation of a fatty acid by joining it with Coenzyme A.
Sequential removal of two-carbon units in the form of acetyl-CoA from the fatty acid.
The general reaction can be represented as:
CH3(CH2)n-CH2-CH2-COO^- \rightarrow CH3(CH2)n-CO\sim CoA + CH_3-CO \sim CoA
Activation of Fatty Acids
Involves joining a fatty acid with Coenzyme A to form a thioester bond (RCO~SCoA).
The reaction occurs in two steps and is catalyzed by thiokinase (acyl CoA synthetase):
FA + HSCoA + ATP \rightarrow FA\sim CoA + AMP + PPi
PPi + H_2O \rightarrow 2 Pi
Overall: FA + HSCoA + ATP \rightarrow FA\sim CoA + AMP + 2 Pi
Location:
Long-chain fatty acids (LCFA): outer mitochondrial membrane
Short- and medium-chain fatty acids: mitochondrial matrix
Transport of LCFA
Carnitine shuttle is required to transport long-chain fatty acids into the mitochondrial matrix.
The transport system includes:
A carrier molecule (carnitine).
Two enzymes: Carnitine palmitoyl transferase I and II.
Membrane transport protein (translocase).
Malonyl-CoA regulates this transport system.
Transport of SCFAs and MCFAs
Short-chain fatty acids (SCFAs) and medium-chain fatty acids (MCFAs) directly enter the mitochondria without the carnitine shuttle.
In the mitochondria, they are converted to Acetyl-CoA, which enters the Krebs cycle for energy production.
Unlike LCFA transport, SCFA and MCFA entry is not regulated by malonyl CoA.
Application: Carnitine
Carnitine is synthesized from Lysine and Methionine in the liver and kidney and is also obtained from meat products.
Other functions include:
Export of branched-chain acyl groups from mitochondria.
Binding to acyl groups derived from amino acid metabolism for excretion, acting as a scavenger.
The body contains ~97% of all carnitine.
Mitochondrial ACC2 regulates fatty acid degradation.
Application: Carnitine Deficiencies
Primary carnitine deficiency:
Defects in a membrane transporter prevent carnitine uptake by cardiac and skeletal muscles and the kidneys, leading to carnitine excretion.
Treatment: carnitine supplementation.
Secondary carnitine deficiency:
Caused by taking valproic acid (antiseizure), leading to decreased renal reabsorption.
Defective fatty acid oxidation leads to the accumulation of acyl-carnitines, which are excreted in urine.
Liver diseases leading to decreased carnitine synthesis.
CPT-I deficiency: affects the liver, preventing the use of LCFA, resulting in no energy for glucose synthesis during fasting, leading to severe hypoglycemia, coma, and death.
CPT-II deficiency: affects the liver, cardiac muscle, and skeletal muscle.
Treatment: avoidance of fasting, a diet high in carbohydrates and low in fat, supplemented with medium-chain TAG.
β-Oxidation Steps
Step 1: Oxidation by Acyl CoA dehydrogenases
Fatty acyl CoA is converted to Enoyl CoA, producing FADH2.
Step 2: Hydration by Enoyl CoA hydratase
Enoyl CoA is hydrated to form 3-Hydroxyacyl CoA.
Step 3: Oxidation by 3-Hydroxyacyl CoA dehydrogenase
3-Hydroxyacyl CoA is oxidized to 3-Ketoacyl CoA, producing NADH + H+.
Step 4: Thiolytic Cleavage by thiolase
3-Ketoacyl CoA is cleaved to produce Acetyl CoA and a shortened Fatty acyl CoA.
The general scheme:
CH3(CH2)x-CH2-CH2-C-S-CoA \rightarrow CH3(CH2)x-C-S-CoA + CH_3-C-S-CoANumber of cycles: (n/2)-1
Energy Yield from FA Oxidation
Example: Oxidation of C16 Fatty Acid (Palmitic Acid):
CH3-(CH2)_{14}-CO-CoA
Produces 8 Acetyl CoA, 7 FADH2, and 7 NADH
Calculations:
7 FADH2 yields 14 ATP
7 NADH yields 21 ATP
8 Acetyl CoA yields 96 ATP
Activation of the Acid consumes 2 ATP.
Net yield: 129 ATP per mole of C16 Fatty Acid.
Induction of Gluconeogenesis and Fates of Acetyl CoA
Acetyl-CoA, produced from β-oxidation, can have several fates:
Ketogenesis: Production of ketone bodies.
TCA Cycle: Oxidation in the tricarboxylic acid cycle.
Lipogenesis: Conversion back into fatty acids.
B-Oxidation of fatty acids yields Acetyl-CoA, which can enter the TCA cycle or be used for ketogenesis.
Gluconeogenesis is induced, leading to the synthesis of glucose from precursors like pyruvate
Application: MCAD Deficiency
There are 4 isozymes of fatty acyl CoA dehydrogenase for SCFA, MCFA, LCFA, and VLCFA.
Medium-chain fatty acyl CoA dehydrogenase (MCAD) deficiency is an autosomal-recessive disorder.
It is the most common inborn error of β-oxidation (1:14,000 births worldwide), with a higher incidence among Caucasians of Northern European descent.
Results in a decreased ability to oxidize MCFAs, leading to a lack of energy, severe hypoglycemia, and hypoketonemia.
Treatment: avoidance of fasting, regular and frequent meals and snacks, and a diet high in carbohydrates and low in fat.
Oxidation of Odd-Numbered FAs
Starts as cycles of beta-oxidation producing acetyl-CoA and propionyl-CoA
If deficient, metabolic acidosis and neurologic manifestations
Unsaturated Fatty Acid Oxidation
Monounsaturated fatty acid β-oxidation
But this reaction is skipped resulting in one less FADH2 -> loss of electrons
Polyunsaturated FA
Polyunsaturated FA will also need an NADPH-dependent 2,4-dienoyl CoA reductase in addition to the isomerase. -> loss of electrons
Peroxisomal β-oxidation
Involves Very Long Chain Fatty Acids (VLCFA) with ≥22 carbons.
Zellweger syndrome: a peroxisomal biogenesis disorder
X-linked adrenoleukodystrophy: dysfunctional transport VLCFA across the peroxisomal membrane
Accumulation of VLCFAs
Loss of electrons
FAD Containing acyl CoA Oxidase
Peroxisomal α-oxidation of branched chain FAs
Phytanic acid, a breakdown product of Chlorophyll, is activated by CoA, transported into the peroxisome, and hydroxylated by phytanoyl CoA α-hydroxylase (PhyH), and carbon 1 is released as CO2.
When fully degraded, it generates formyl-CoA, propionyl-CoA, acetyl-CoA, and 2-methyl-propionyl-CoA.
Refsum disease is an autosomal-recessive disorder caused by a deficiency of peroxisomal PhyH.
ω-Oxidation
A minor pathway of the smooth endoplasmic reticulum (SER).
Generates dicarboxylic acids.
Upregulated in certain conditions such as MCAD deficiency.
Lipids and Energy
TAGs are the body’s major fuel storage reserve.
The complete oxidation of fatty acids to CO2 and H2O generates 9 kcal/g of fat, compared to 4 kcal/g for protein or carbohydrate.
Exercise and sources of energy
Energy for muscle contraction
ATP ADP Anaerobic metabolism
Creatine phosphate Creatine Creatine kinase Active Muscle
Aerobic metabolism